Droplet Digital PCR

ddPCR symposium agenda

11:00 to 11:30 CET / 10:00 to 10:30 GMT

ENABLING YOU TO WRITE THE FUTURE OF DIGITAL PCR.


Alessandro Martino, PhD
BioPharma Sales Specialist, Genomics, Bio-Rad Laboratories

Reg Chopra
LSG Marketing Manager EMEA, Bio-Rad Laboratories 

11:30-12:30 CET / 10:30-11:30 GMT

DETECTION OF HOTSPOT MUTATIONS BY DDPCR USING DROP-OFF ASSAY: ESR1 EXAMPLE.

Emmanuelle Jeannot, PhD
Praticien Scientifique, Pôle de Médecine Diagnostique et Théranostique, Institut Curie, Paris, France

PLASMID COPY NUMBER QUANTIFICATION DURING ESCHERICHIA COLI FERMENTATION PROCESS.

Loic Benair, PhD
Associate Scientist, Microbiology unit - Analytical Sciences Department, Sanofi, France

MONITORING SARS-COV-2 IN WASTEWATER WITH DDPCR.

Ion Gutierrez, PhD
Senior Research Associate, Department of Biotechnology and Systems Biology, NIB-National Institute of Biotechnology, Slovenia

12:30-13:30 CET / 11:30-12:30 GMT

13:30-14:30 CET / 12:30-13:30 GMT

DETECTION OF TP53 VARIANTS IN PAPANICOLAU TEST FOR EARLY DIAGNOSIS OF HIGH GRADE SEROUS OVARIAN CANCER.

Sergio Marchini, PhD
Head Translational Genomic Unit, Cancer Pharmacology Lab., Dept. of Oncology, IRCCS-""Mario Negri"" Institute, Milano, Italy

DROPLET DIGITAL PCR IS BECOMING NEW GOLDEN STANDARD FOR GENE THERAPY VIRAL VECTORS QUANTIFICATION.

David Dobnik, PhD
Assist. Professor, Department of Biotechnology and Systems Biology, NIB-National Institute of Biotechnology, Slovenia

IMPLEMENTATION AND VALIDATION OF A POOLING STRATEGY FOR A SUSTAINABLE SCREENING CAMPAIGN FOR THE PRESENCE OF SARS-COV-2

Michela Bulfoni, PhD
Research Collaborator, Institute of Surgical Pathology, University Hospital of Udine Italy

Cancelled. Due to her increased work commitments in COVID testing at this time, Dr Bulfoni will be unavailable to present as planned. We thank her for having agreed to present and understand the change in her priorities today. We apologise for this inconvenience to all the symposium registrants.

14:30-15:30 CET / 13:30-14:30 GMT

DDPCR FOR THE DETERMINATION OF MSI STATUS IN PATIENTS WITH CANCER.

Alexandre Harlé, PhD
Assistant Professor at Institut de Cancérologie de Lorraine and Université de Lorraine, Faculté de Pharmacie, CNRS UMR7039 CRAN, Nancy, France

SIMPLIFICATION OF RESIDUAL HOST CELL DNA ANALYTICS IN LATE STAGE PROCESS DEVELOPMENT OF THERAPEUTIC BIOMOLECULES USING DDPCR.

Jan Michel Falke, PhD
Head of Laboratory, R&D Biologics Development, Bioprocess Analytics, Sanofi, Germany

HIGH-THROUGHPUT SARS-COV-2 TESTING USING DDPCR: EXPERIENCES FROM A CENTRALIZED CLIA LABORATORY IN THE UNITED STATES.

Gary Pestano, PhD
Chief Development Officer, Biodesix, USA

15:30-16:00 CET / 14:30-15:00 GMT

16:00-17:00 CET / 15:00-16:00 GMT

TIPS & TRICKS: SHARING A DECADE OF EXPERIENCE IN DDPCR


Francisco Bizouarn, PhD
Senior Tech Support Manager, DBG, Bio-Rad Laboratories

Koen de Gelas, PhD
ddPCR Regional Specialist Northern Europe, Bio-Rad Laboratories

Eddy van Collenburg, PhD
ddPCR Regional Specialist, Channel Partners, Bio-Rad Laboratories